CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
prednisone in symptomatic bone-only metastatic castration-resistant prostate cancer (mCRPC)Open-label, randomized phase II trial in ...
Phase 2
Milano, Italy and 15 other locations
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...
Phase 1, Phase 2
Milan, Italy and 50 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Milan, Italy and 131 other locations
The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's...
Phase 3
Milan, Italy and 59 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Milan, Italy and 321 other locations
This is a phase III, randomized, open-label, multi-center study to assess the efficacy of treatment intensification with docetaxel plus apalutamide a...
Phase 3
Milan, Italy and 55 other locations
Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...
Phase 3
Milan, Italy and 51 other locations
of ADT +/- darolutamide in castration-naïve de novo metastatic prostate cancer patients with vulnerable functional ability who have...
Phase 3
Milano, Italy and 89 other locations
pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients with Metastatic Prostate...
Phase 1, Phase 2
Milan, Italy and 19 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Cremona, Italy and 240 other locations
Clinical trials
Research sites
Resources
Legal